Blackberry announced the product of their collaboration with NantHealth: a healthcare app for doctors and nurses who use their smartphones.
BlackBerry Ltd.’s investment in healthcare technology has produced its first applications targeted at doctors and nurses who use its smartphones.
The Canadian phone maker’s networks and devices will run apps developed by Los Angeles-based NantHealth, a healthcare company run by billionaire Patrick Soon-Shiong. BlackBerry invested in NantHealth last April.
Health care is a key target for BlackBerry, said Chief Executive Officer John Chen. The first part of the deal will connect physicians’ BlackBerrys with a NantHealth system that analyzes tumors and recommends treatment options. It will be available early next year, the companies said. More applications are planned, Chen and Soon-Shiong said in a joint phone interview.
“We do have many hospitals and clinical groups that use our devices,” Chen said. “But what we’re talking here is much larger-scale if we become successful.”
Chen, who has said he plans to double software revenue to $500 million by March 2016, declined to comment on what the health-care business could be worth. Since he took over the Waterloo, Ontario-based company a year ago, Chen has narrowed his focus to industries that demand high levels of security like banking, government and health care.
Link to the news on Bloomberg: http://bloom.bg/1ubdIeV
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen